Literature DB >> 2870332

Serum trimethoprim and sulphamethoxazole levels in AIDS.

F J Bowden, P J Harman, C R Lucas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870332     DOI: 10.1016/s0140-6736(86)90958-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.

Authors:  B L Lee; S Safrin; V Makrides; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Hypoglycemia induced by co-trimoxazole in AIDS.

Authors:  A Schattner; E Rimon; L Green; R Coslovsky; Z Bentwich
Journal:  BMJ       Date:  1988-09-17

Review 3.  Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Authors:  H F Vöhringer; K Arastéh
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

4.  Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy.

Authors:  J Blaser; B Joos; M Opravil; R Lüthy
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

5.  Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia.

Authors:  B Joos; J Blaser; M Opravil; J P Chave; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

6.  Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole.

Authors:  A J van der Ven; T B Vree; E W van Ewijk-Beneken Kolmer; P P Koopmans; J W van der Meer
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

7.  Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study.

Authors:  Bao D Dao; Jason N Barreto; Robert C Wolf; Ross A Dierkhising; Matthew F Plevak; Pritish K Tosh
Journal:  Curr Ther Res Clin Exp       Date:  2014-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.